Skip to main content
SpringerLink
Log in

Concentration of Lipid, apoprotein-B and testosterone in patients with coronarographic findings

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The relationship between lipid, apolipoprotein-B and testosterone concentration and indicated coronarography was followed in male patients assigned into two age groups (under and over 50 years). Patients without a positive finding on coronary vessels served as controls. Patients of both age groups with a positive coronarographic finding showed an enhanced apolipoprotein-B and a decreased cholesterol concentration in the HDL2-high density lipoprotein subfraction. Like-wise, testosterone level was also decreased in the two age groups. It appears that a lowered testosterone level may indirectly intervene into lipoprotein metabolism, or may affect the apolipoprotein-B level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

HDL:

high density lipoprotein

HDL-Ch:

high density lipoprotein-cholesterol

LDL:

low density lipoprotein

LPL:

lipoprotein lipase

VLDL:

very low density lipoprotein

References

  1. Anderson DW, Nichols AV, Pan SS, Lindgren FT (1978) High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis 29:161–179

    Google Scholar 

  2. Berchtold P, Berger M (1978) HDL-Cholesterin, ein Schutzfaktor gegen die koronare Herzkrankheit. Dtsch Med Wochenschr 103:1537–1540

    Google Scholar 

  3. Carlson LA (1963) Determination of serum triglycerides. J Atheroscler Res 3:33–36

    Google Scholar 

  4. Chait A, Albers JJ, Brunzell JD (1980) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia. Eur J Clin Invest 10:17–22

    Google Scholar 

  5. Curry MD, Gustafson A, Alaupovic P, McConathy WJ (1978) Electroimmunoassay, radial evaluated for quantification of human apolipoprotein-B. Clin Chem 24:280–286

    Google Scholar 

  6. Glueck CJ, Scheel D, Fishback J, Steiner P (1972) Progestagens anabolic-adrogenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes. Lipids 7:110–113

    Google Scholar 

  7. Gofman JW, Young W, Tandy R (1966) Ischemic heart disease atherosclerosis and longevity. Circulation 34:679

    Google Scholar 

  8. Goldstein JL, Brown MS (1974) Binding and degradation of low density lipoproteins by cultured human fibroblasts. J Biol Chem 249:5153–5162

    Google Scholar 

  9. Goldstein JL, Brown MS (1977) The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 46:897–930

    Google Scholar 

  10. Gutai J, LaPorte R, Kuller L, Dai FW, Flavo-Gerard L, Caggiula A (1981) Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol 48:897–902

    Google Scholar 

  11. Haffner SM, Rampratap S, Kushwaha S, Foster DM, Applebaum-Bowden D, Hazzard WR (1983) Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 34:413–420

    Google Scholar 

  12. Havel RJ, Eder HA, Bragdon JH (1955) Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345–1353

    Google Scholar 

  13. Hazzard WR, Kushwaha RS, Applebaum-Bowden D, Haffner SM, Steinmetz A, Foster DM (1984) Chylomicron very low-density lipoprotein apolipoprotein-B metabolism: Mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia. Metabolism 33:873–881

    Google Scholar 

  14. Hromadová M, Háčik T, Riečanský I (1982) Plasma apolipoprotein-B in male patients examined by angiography. 4th Dresden Symposium International Symposium on Lipoproteins and Atherosclerosis June 10–12, 1982, Dresden GDR, pp 150–153

  15. Kannel WB (1974) The role cholesterol in coronary atherogenesis. Med Clin North Am 58:363–379

    Google Scholar 

  16. Mendoza SG, Osuna A, Zerpa A, Gartside PS, Glueck CJ (1981) Hypertriglyceridemia and hypoalfalipoproteinemia in azoospermatic and oligospermatic young men: relationships of endogenous testosterone to triglyceride and high density lipoprotein cholesterol metabolism. Metabolism 30:481–486

    Google Scholar 

  17. Mertz DP (1978) Vasoprotektive und vasoaggressive Eigenschaften von Lipoproteinen in Serum. Münch Med Wochenschr 120:1671–1672

    Google Scholar 

  18. Mertz DP (1980) Atherosclerose Index (LDL/HDL): Risikoindikator bei Störungen des Fettstoffwechsels. Med Klinik 75:159–161

    Google Scholar 

  19. Nörday A, Aakvaag A, Thelle D (1979) Sex hormones and high density lipoproteins in healthy males. Atherosclerosis 34:431–436

    Google Scholar 

  20. Patsch JR, Gotto AM (1979) Die Rolle der HDL im Katabolizmus triglyceridreicher Lipoproteine. Internationales Symposium: Neue Aspekte Diagnostik und Therapie von Fettstoffwechselstörungen 12–13 Mai 1979, Wien

  21. Phillips GB (1977) Relationship between serum sex-hormones and glucose, insulin and lipid abnormalities in men with myocardial infraction. Proc Nat Acad Sci USA 74:1729–1733

    Google Scholar 

  22. Reuter W (1978) Sekundäre Hyperlipoproteinämien. Z Gesamte Inn Med 33:817–822

    Google Scholar 

  23. Reuter W, Herrmann W (1981) Klinische Bedeutung des HDL-Cholesterols. Z Gesamte Inn Med 36:473–479

    Google Scholar 

  24. Rudel LL, Morris MD (1973) Determination of cholesterol using o-phtalaldehyde. J Lipid Res 14:364–366

    Google Scholar 

  25. Singurdsson G, Nicoll A, Lewis B (1976) Metabolism of very low density lipoproteins in hypetriglyceridemia: studies of apolipoprotein-B kinetics in man. Eur J Clin Invest 6:167–177

    Google Scholar 

  26. Solyom A (1972) Effects of androgens on serum lipids and lipoproteins. Lipids 7:100–105

    Google Scholar 

  27. Šeböková E, Kolena J (1978) Characterization of specific prostaglandin E1 receptor in isolated rat Leydig cells. Endocrinol Exp 12:147–156

    Google Scholar 

  28. Vander Heiden GL, Barboriak JJ, Sasse EA, Yorde DE (1984) Correlation of the extent of coronary occlusion with apo-B levels. Atherosclerosis 50:29–33

    Google Scholar 

  29. Whayne ThF, Alaupovic P, Curry MD, Lee ET, Anderson PS, Schechter E (1981) Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Artherosclerosis 39:411–424

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Experimental Endocrinology, Centre of Physiological Sciences, Slovak Academy of Sciences, Bratislava

    M. Hromadová & T. Háčik

  2. Institute of Cardiovascular Diseases, Bratislava, Czechoslovakia

    I. Riečanský

Authors
  1. M. Hromadová
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Háčik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Riečanský
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hromadová, M., Háčik, T. & Riečanský, I. Concentration of Lipid, apoprotein-B and testosterone in patients with coronarographic findings. Klin Wochenschr 63, 1071–1074 (1985). https://doi.org/10.1007/BF01739675

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01739675

Key words

Search

Navigation